DBD vs PSA · P/E 28, rev $3.75B vs rev $4.82B
Diebold Nixdorf, Incorporated (DBD) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
PSA (PSA) common stock.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. PSA currently screens at market cap $0.
Not investment advice. Open the DBD and PSA stock pages for the full models.
Not investment advice.